Pleomorphic adenoma and carcinoma ex pleomorphic adenoma:: immunohistochemical demonstration of the association between tenascin expression and malignancy

被引:15
作者
Félix, A
Rosa, JC
Fonseca, I
Cidadao, A
Soares, J
机构
[1] Inst Portugues Oncol Francisco Gentil, Serv Anat Patol, P-1093 Lisbon, Portugal
[2] Univ Lisbon, Fac Med, Inst Histol & Embriol, Lisbon, Portugal
关键词
carcinoma ex pleomorphic adenoma; extracellular matrix; pleomorphic adenoma; salivary gland tumours; tenascin;
D O I
10.1111/j.1365-2559.2004.01924.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Aims: To investigate tenascin expression in salivary gland tumours. Tenascin is a matricellular protein that has been studied in several tumour types. Its expression has been correlated with tumour morphogenesis as well as with local invasiveness and tumour metastatic behaviour. Methods and results: The distribution pattern of tenascin in a series of 63 pleomorphic adenomas (PA) and 20 carcinomas ex- pleomorphic adenoma (Ca ex PA) was studied immunohistochemically. Ten normal adult salivary glands were used as controls. Tenascin surrounded the excretory ducts of normal adult salivary gland tissue. It was absent in the basement membrane compartment of both benign and malignant mixed tumours. In the interstitial compartment of the extracellular matrix, the fibro-hyaline type expressed tenascin in a statistically significantly (P < 0.001) lower number of PA cases (25%) in comparison with both malignant and benign areas of Ca ex PA (75% and 90%, respectively). In the Ca ex PA group, a statistically significantly difference (P < 0.001) was found in the frequency of tenascin deposits around aggregates of neoplastic cells between metastasizing (73%) and non-metastasizing neoplasms (0%). Conclusions: These findings strongly support the hypothesis that tenascin deposition is involved in the mechanisms of malignant transformation of pleomorphic adenomas into carcinomas as well as being associated with clinical disease progression.
引用
收藏
页码:187 / 192
页数:6
相关论文
共 29 条
[1]  
Adams M, 2002, CANCER RES, V62, P3289
[2]   TENASCIN DURING GUT DEVELOPMENT - APPEARANCE IN THE MESENCHYME, SHIFT IN MOLECULAR-FORMS, AND DEPENDENCE ON EPITHELIAL MESENCHYMAL INTERACTIONS [J].
AUFDERHEIDE, E ;
EKBLOM, P .
JOURNAL OF CELL BIOLOGY, 1988, 107 (06) :2341-2349
[3]  
BATSAKIS JG, 1991, HISTOLOGICAL TYPING
[4]  
BATSAKIS JG, 1997, ADV ANAT PATHOL, V4, P176
[5]   PHASE-I STUDIES OF TREATMENT OF MALIGNANT GLIOMAS AND NEOPLASTIC MENINGITIS WITH I-131 RADIOLABELED MONOCLONAL-ANTIBODIES ANTI-TENASCIN 81C6 AND ANTI-CHONDROITIN PROTEOGLYCAN SULFATE ME1-14 F(AB')(2) - A PRELIMINARY-REPORT [J].
BIGNER, DD ;
BROWN, M ;
COLEMAN, RE ;
FRIEDMAN, AH ;
FRIEDMAN, HS ;
MCLENDON, RE ;
BIGNER, SH ;
ZHAO, XG ;
WIKSTRAND, CJ ;
PEGRAM, CN ;
KERBY, T ;
ZALUTSKY, MR .
JOURNAL OF NEURO-ONCOLOGY, 1995, 24 (01) :109-122
[6]  
CHIQUETEHRISMAN.R, 1999, GUIDEBOOK EXTRACELLU, P486
[7]  
CHIQUETEHRISMANN R, 1993, SEMIN CANCER BIOL, V4, P301
[8]   Phase I trial results of iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with newly diagnosed malignant gliomas [J].
Cokgor, I ;
Akabani, G ;
Kuan, CT ;
Friedman, HS ;
Friedman, AH ;
Coleman, RE ;
McLendon, RE ;
Bigner, SH ;
Zhao, XG ;
Garcia-Turner, AM ;
Pegram, CN ;
Wikstrand, CJ ;
Shafman, TD ;
Herndon, JE ;
Provenzale, JM ;
Zalutsky, MR ;
Bigner, DD .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (22) :3862-3872
[9]   Hyalinizing clear cell carcinoma of salivary glands:: a study of extracellular matrix [J].
Félix, A ;
Rosa, JC ;
Nunes, JFM ;
Fonseca, I ;
Cidadao, A ;
Soares, J .
ORAL ONCOLOGY, 2002, 38 (04) :364-368
[10]   Laminin and collagen IV in pleomorphic adenoma and carcinoma ex-pleomorphic adenoma:: An immunohistochemical study [J].
Félix, A ;
Rosa, JC ;
Fonseca, I ;
Cidadao, A ;
Soares, J .
HUMAN PATHOLOGY, 1999, 30 (08) :964-969